Powl Brian T. 4
4 · Kura Oncology, Inc. · Filed Sep 29, 2025
Insider Transaction Report
Form 4
Powl Brian T.
Chief Commercial Officer
Transactions
- Award
Common Stock
2025-09-27+48,900→ 108,567 total - Sale
Common Stock
2025-09-29$8.94/sh−8,891$79,505→ 99,676 total
Footnotes (1)
- [F1]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 9/27/25.